NCT05309525View on ClinicalTrials.gov

Effect of Oral TXA on Buttock Bruising Post CCH Injections in Adult Females

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

October 1, 2022

Conditions
Cellulite
Interventions
DRUG

Collagenase Clostridium Histolyticum-Aaes

subjects will be injected with up to 0.84 mg of QWO as 12 subcutaneous injections (0.3-mL injection administered as three 0.1-mL aliquots per injection), dependent on the amount of dimples (0.3 ml per dimple).

DRUG

Lysteda 650 MG Oral Tablet

Subjects will be given the therapeutic dose of tranexamic acid for menorrhagia, which is 1300 mg PO TID for up to 5 days during menstruation

Trial Locations (1)

10021

Luxurgery, New York

All Listed Sponsors
lead

Luxurgery

INDUSTRY